FSD Pharma (TSE:HUGE) has released an update.
FSD Pharma Inc., a biopharmaceutical company, successfully conducted its annual general and special meeting, with shareholders electing director nominees and re-appointing MNP LLP as the auditor. The meeting saw approval for a share consolidation resolution, with a significant turnout and support for all director nominees.
For further insights into TSE:HUGE stock, check out TipRanks’ Stock Analysis page.
